Amedeo Smart

Free Medical Literature Service

 

Amedeo

Vaccines
  Free Subscription

Articles published in
J Virol
    December 2023
  1. ZAYOU L, Prakash S, Dhanushkodi NR, Quadiri A, et al
    A multi-epitope/CXCL11 prime/pull coronavirus mucosal vaccine boosts the frequency and the function of lung-resident memory CD4(+) and CD8(+) T cells and enhanced protection against COVID-19-like symptoms and death caused by SARS-CoV-2 infection.
    J Virol. 2023 Dec 1:e0109623. doi: 10.1128/jvi.01096.
    >> Share

    November 2023
  2. KEELAPANG P, Ketloy C, Puttikhunt C, Sriburi R, et al
    Heterologous prime-boost immunization induces protection against dengue virus infection in cynomolgus macaques.
    J Virol. 2023;97:e0096323.
    >> Share

  3. ZHU X, Wang L, Gong L, Zhai Y, et al
    LORF9 of Marek's disease virus is involved in the early cytolytic replication of B lymphocyte and can act as a target for gene deletion vaccine development.
    J Virol. 2023 Nov 28:e0157423. doi: 10.1128/jvi.01574.
    >> Share

  4. KAO C-F, Liu C-Y, Hsieh C-L, Carillo KJD, et al
    Structural and functional analyses of viral H2 protein of the vaccinia virus entry fusion complex.
    J Virol. 2023 Nov 17:e0134323. doi: 10.1128/jvi.01343.
    >> Share

  5. NIU X, Liu M, Yang S, Xu J, et al
    A recombination-resistant genome for live attenuated and stable PEDV vaccines by engineering the transcriptional regulatory sequences.
    J Virol. 2023 Nov 16:e0119323. doi: 10.1128/jvi.01193.
    >> Share

  6. ZENG R, Fu J, Pan W, Zhan Z, et al
    Low-temperature immunization attenuates the residual virulence of orf074r gene-deleted infectious spleen and kidney necrosis virus: a candidate immersion vaccine.
    J Virol. 2023 Nov 7:e0128923. doi: 10.1128/jvi.01289.
    >> Share

  7. SUN W, Xu J, Wang Z, Li D, et al
    Clade 2.3.4.4 H5 chimeric cold-adapted attenuated influenza vaccines induced cross-reactive protection in mice and ferrets.
    J Virol. 2023 Nov 2:e0110123. doi: 10.1128/jvi.01101.
    >> Share

  8. RIJNINK WF, Stadlbauer D, Puente-Massaguer E, Okba NMA, et al
    Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses.
    J Virol. 2023 Nov 2:e0164622. doi: 10.1128/jvi.01646.
    >> Share

    October 2023
  9. BARTSCH YC, Cizmeci D, Yuan D, Mehta N, et al
    Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine.
    J Virol. 2023 Oct 30:e0077123. doi: 10.1128/jvi.00771.
    >> Share

  10. HAO X, Li J, Wang J, Zhou Z, et al
    Co-administration of chicken IL-2 alleviates clinical signs and replication of the ILTV chicken embryo origin vaccine by pre-activating natural killer cells and cytotoxic T lymphocytes.
    J Virol. 2023 Oct 26:e0132223. doi: 10.1128/jvi.01322.
    >> Share

  11. JOHNSON RM, Ardanuy J, Hammond H, Logue J, et al
    Diet-induced obesity and diabetes enhance mortality and reduce vaccine efficacy for SARS-CoV-2.
    J Virol. 2023 Oct 17:e0133623. doi: 10.1128/jvi.01336.
    >> Share

  12. LI J, Zhao S, Zhang B, Huang J, et al
    A novel recombinant S-based subunit vaccine induces protective immunity against porcine deltacoronavirus challenge in piglets.
    J Virol. 2023 Oct 17:e0095823. doi: 10.1128/jvi.00958.
    >> Share

  13. MISPLON JA, Lo CY, Crabbs TA, Price GE, et al
    Adenoviral-vectored universal influenza vaccines administered intranasally reduce lung inflammatory responses upon viral challenge 15 months post-vaccination.
    J Virol. 2023 Oct 13:e0067423. doi: 10.1128/jvi.00674.
    >> Share

  14. VAN DUIJN J, Stieh D, Fernandez N, King D, et al
    Mosaic HIV-1 vaccination induces anti-viral CD8(+) T cell functionality in the phase 1/2a clinical trial APPROACH.
    J Virol. 2023 Oct 9:e0112623. doi: 10.1128/jvi.01126.
    >> Share

  15. MCMAHON M, Tan J, O'Dell G, Kirkpatrick Roubidoux E, et al
    Immunity induced by vaccination with recombinant influenza B virus neuraminidase protein breaks viral transmission chains in guinea pigs in an exposure intensity-dependent manner.
    J Virol. 2023 Oct 6:e0105723. doi: 10.1128/jvi.01057.
    >> Share

    September 2023
  16. LI J, Song J, Zhou S, Li S, et al
    Development of a new effective African swine fever virus vaccine candidate by deletion of the H240R and MGF505-7R genes results in protective immunity against the Eurasia strain.
    J Virol. 2023 Sep 28:e0070423. doi: 10.1128/jvi.00704.
    >> Share

  17. MCCOOL RS, Musayev M, Bush SM, Derrien-Colemyn A, et al
    Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein elicits antibodies targeting a membrane-proximal epitope.
    J Virol. 2023 Sep 22:e0092923. doi: 10.1128/jvi.00929.
    >> Share

  18. LAN W, Quan L, Li Y, Ou J, et al
    Isolation of novel simian adenoviruses from macaques for development of a vector for human gene therapy and vaccines.
    J Virol. 2023 Sep 15:e0101423. doi: 10.1128/jvi.01014.
    >> Share

  19. XING M, Wang Y, Wang X, Liu J, et al
    Broad-spectrum vaccine via combined immunization routes triggers potent immunity to SARS-CoV-2 and its variants.
    J Virol. 2023 Sep 14:e0072423. doi: 10.1128/jvi.00724.
    >> Share

  20. RAO PG, Lambert GS, Upadhyay C
    Broadly neutralizing antibody epitopes on HIV-1 particles are exposed after virus interaction with host cells.
    J Virol. 2023 Sep 8:e0071023. doi: 10.1128/jvi.00710.
    >> Share

    June 2023
  21. ZENG R, Pan W, Lin Y, Liang M, et al
    A Safe and Efficient Double-Gene-Deleted Live Attenuated Immersion Vaccine to Prevent the Disease Caused by the Infectious Spleen and Kidney Necrosis Virus.
    J Virol. 2023 Jun 29:e0085723. doi: 10.1128/jvi.00857.
    >> Share

  22. WU Q, Zhang Y, Wang C, Hou Y, et al
    Short-Chain Fatty Acids Alleviate Vancomycin-Caused Humoral Immunity Attenuation in Rabies-Vaccinated Mice by Promoting the Generation of Plasma Cells via Akt-mTOR Pathway.
    J Virol. 2023 Jun 20:e0065623. doi: 10.1128/jvi.00656.
    >> Share

  23. GOFFIN E, Du X, Hemmi S, Machiels B, et al
    A Single Oral Immunization with a Replication-Competent Adenovirus-Vectored Vaccine Protects Mice from Influenza Respiratory Infection.
    J Virol. 2023 Jun 20:e0013523. doi: 10.1128/jvi.00135.
    >> Share

    May 2023
  24. ZHU G, Ren J, Li D, Ru Y, et al
    Combinational Deletions of MGF110-9L and MGF505-7R Genes from the African Swine Fever Virus Inhibit TBK1 Degradation by an Autophagy Activator PIK3C2B To Promote Type I Interferon Production.
    J Virol. 2023;97:e0022823.
    >> Share

  25. REZENDE W, Ye X, Angelo LS, Carisey AF, et al
    The Efficiency of p27 Cleavage during In Vitro Respiratory Syncytial Virus (RSV) Infection Is Cell Line and RSV Subtype Dependent.
    J Virol. 2023;97:e0025423.
    >> Share

    April 2023
  26. SPATZ S, Garcia M, Fuchs W, Loncoman C, et al
    Reconstitution and Mutagenesis of Avian Infectious Laryngotracheitis Virus from Cosmid and Yeast Centromeric Plasmid Clones.
    J Virol. 2023;97:e0140622.
    >> Share

  27. QI X, Feng T, Ma Z, Zheng L, et al
    Deletion of DP148R, DP71L, and DP96R Attenuates African Swine Fever Virus, and the Mutant Strain Confers Complete Protection against Homologous Challenges in Pigs.
    J Virol. 2023;97:e0024723.
    >> Share

  28. SASTRY M, Changela A, Gorman J, Xu K, et al
    Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization.
    J Virol. 2023 Apr 26:e0160422. doi: 10.1128/jvi.01604.
    >> Share

  29. FENG H, Yao L, Zeng Z, Jiang L, et al
    Identification of Embryonic Chicken Proteases Activating Newcastle Disease Virus and Their Roles in the Pathogenicity of Virus Used as In Ovo Vaccine.
    J Virol. 2023 Apr 12:e0032423. doi: 10.1128/jvi.00324.
    >> Share

    March 2023
  30. GONG YM, Wei XF, Zheng YY, Li Y, et al
    Combining Phage Display Technology with In Silico-Designed Epitope Vaccine to Elicit Robust Antibody Responses against Emerging Pathogen Tilapia Lake Virus.
    J Virol. 2023 Mar 28:e0005023. doi: 10.1128/jvi.00050.
    >> Share

  31. STAMOS JD, Rahman MA, Gorini G, Silva de Castro I, et al
    Effect of Passive Administration of Monoclonal Antibodies Recognizing Simian Immunodeficiency Virus (SIV) V2 in CH59-Like Coil/Helical or beta-Sheet Conformations on Time of SIV(mac251) Acquisition.
    J Virol. 2023 Mar 28:e0186422. doi: 10.1128/jvi.01864.
    >> Share

  32. DESROSIERS RC
    The Failure of AIDS Vaccine Efficacy Trials: Where to Go from Here.
    J Virol. 2023 Mar 14:e0021123. doi: 10.1128/jvi.00211.
    >> Share

  33. ABBO SR, Nguyen W, Abma-Henkens MHC, van de Kamer D, et al
    Comparative Efficacy of Mayaro Virus-Like Particle Vaccines Produced in Insect or Mammalian Cells.
    J Virol. 2023 Mar 8:e0160122. doi: 10.1128/jvi.01601.
    >> Share

    February 2023
  34. WANG Y, Ge F, Wang J, Li H, et al
    Mycobacterium bovis BCG Given at Birth Followed by Inactivated Respiratory Syncytial Virus Vaccine Prevents Vaccine-Enhanced Disease by Promoting Trained Macrophages and Resident Memory T Cells.
    J Virol. 2023 Feb 13:e0176422. doi: 10.1128/jvi.01764.
    >> Share

  35. AMANAT F, Clark J, Carreno JM, Strohmeier S, et al
    Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination.
    J Virol. 2023 Feb 13:e0166422. doi: 10.1128/jvi.01664.
    >> Share

  36. KURIAKOSE GIFT S, Wieczorek L, Sanders-Buell E, Zemil M, et al
    Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies.
    J Virol. 2023 Feb 7:e0163522. doi: 10.1128/jvi.01635.
    >> Share

    January 2023
  37. TJARNHAGE E, Brown D, Bogen B, Andersen TK, et al
    Trimeric, APC-Targeted Subunit Vaccines Protect Mice against Seasonal and Pandemic Influenza.
    J Virol. 2023 Jan 31:e0169422. doi: 10.1128/jvi.01694.
    >> Share

  38. GILL AL, Hudson WH, Valanparambil RM, Ahn E, et al
    Longitudinal Analysis of the Phenotype, Transcriptional Profile, and Anatomic Location of Memory CD8 T Cell Subsets after Acute Viral Infection.
    J Virol. 2023;97:e0155622.
    >> Share

  39. SAKABE S, Cubitt B, Martinez-Sobrido L, de la Torre JC, et al
    Molecular Engineering of a Mammarenavirus with Unbreachable Attenuation.
    J Virol. 2023;97:e0138522.
    >> Share

  40. SHIWA-SUDO N, Sakai Y, Iwata-Yoshikawa N, Watanabe S, et al
    Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
    J Virol. 2023 Jan 12:e0136622. doi: 10.1128/jvi.01366.
    >> Share

  41. MCGINNES CULLEN L, Luo B, Wen Z, Zhang L, et al
    The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate.
    J Virol. 2023 Jan 5:e0190022. doi: 10.1128/jvi.01900.
    >> Share

    December 2022
  42. DELVA JL, Daled S, Van Waesberghe C, Almey R, et al
    Proteomic Comparison of Three Wild-Type Pseudorabies Virus Strains and the Attenuated Bartha Strain Reveals Reduced Incorporation of Several Tegument Proteins in Bartha Virions.
    J Virol. 2022;96:e0115822.
    >> Share

  43. GOUMA S, Furey C, Santos JJS, Parkhouse K, et al
    Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation.
    J Virol. 2022 Dec 19:e0172322. doi: 10.1128/jvi.01723.
    >> Share

  44. MEADE P, Strohmeier S, Bermudez-Gonzalez MC, Garcia-Sastre A, et al
    Antigenic Landscape Analysis of Individuals Vaccinated with a Universal Influenza Virus Vaccine Candidate Reveals Induction of Cross-Subtype Immunity.
    J Virol. 2022 Dec 19:e0107022. doi: 10.1128/jvi.01070.
    >> Share

    November 2022
  45. STEPHENS LM, Ross KA, McLellan JS, Narasimhan B, et al
    Long-Lasting Protection Induced by a Polyanhydride Nanovaccine against Respiratory Syncytial Virus in an Outbred Mouse Model.
    J Virol. 2022;96:e0150222.
    >> Share

  46. PHILIP AA, Patton JT
    Generation of Recombinant Rotaviruses Expressing Human Norovirus Capsid Proteins.
    J Virol. 2022;96:e0126222.
    >> Share

  47. HARWOOD OE, Balgeman AJ, Weaver AJ, Ellis-Connell AL, et al
    Transient T Cell Expansion, Activation, and Proliferation in Therapeutically Vaccinated Simian Immunodeficiency Virus-Positive Macaques Treated with N-803.
    J Virol. 2022 Nov 15:e0142422. doi: 10.1128/jvi.01424.
    >> Share

    October 2022
  48. BRICE AM, Rozario AM, Rawlinson SM, David CT, et al
    Lyssavirus P Protein Isoforms Diverge Significantly in Subcellular Interactions Underlying Mechanisms of Interferon Antagonism.
    J Virol. 2022;96:e0139622.
    >> Share

  49. DING M, Dang W, Liu H, Zhang K, et al
    Sequential Deletions of Interferon Inhibitors MGF110-9L and MGF505-7R Result in Sterile Immunity against the Eurasia Strain of Africa Swine Fever.
    J Virol. 2022;96:e0119222.
    >> Share

  50. ELLIS-CONNELL AL, Balgeman AJ, Harwood OE, Moriarty RV, et al
    Control of Simian Immunodeficiency Virus Infection in Prophylactically Vaccinated, Antiretroviral Treatment-Naive Macaques Is Required for the Most Efficacious CD8 T Cell Response during Treatment with the Interleukin-15 Superagonist N-803.
    J Virol. 2022 Oct 3:e0118522. doi: 10.1128/jvi.01185.
    >> Share

  51. BONIFACIO JPPL, Williams N, Garnier L, Hugues S, et al
    Optimizing the Live Attenuated Influenza A Vaccine Backbone for High-Risk Patient Groups.
    J Virol. 2022 Oct 3:e0087122. doi: 10.1128/jvi.00871.
    >> Share

    September 2022
  52. CHABOT S, Gimie Y, Obeid K, Kim J, et al
    Enhanced In Vitro and In Vivo Potency of a T Cell Epitope in the Ebola Virus Glycoprotein Following Amino Acid Replacement at HLA-A*02:01 Binding Positions.
    J Virol. 2022;96:e0116621.
    >> Share

  53. REDDY VRAP, Nazki S, Brodrick AJ, Asfor A, et al
    Evaluating the Breadth of Neutralizing Antibody Responses Elicited by Infectious Bursal Disease Virus Genogroup A1 Strains Using a Novel Chicken B-Cell Rescue System and Neutralization Assay.
    J Virol. 2022;96:e0125522.
    >> Share

  54. DU Q, Yang X, Ma M, Zhang Q, et al
    The gC1qR Binding Site Mutant PCV2 Is a Potential Vaccine Strain That Does Not Impair Memory CD4(+) T-Cell Generation by Vaccines.
    J Virol. 2022 Sep 19:e0095922. doi: 10.1128/jvi.00959.
    >> Share

  55. SIA ZR, Chiem K, Huang WC, Seffouh A, et al
    Respiratory Vaccination with Hemagglutinin Nanoliposomes Protects Mice from Homologous and Heterologous Strains of Influenza Virus.
    J Virol. 2022 Sep 15:e0100622. doi: 10.1128/jvi.01006.
    >> Share

  56. AO Z, Ouyang MJ, Olukitibi TA, Warner B, et al
    A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.
    J Virol. 2022 Sep 7:e0133722. doi: 10.1128/jvi.01337.
    >> Share

    August 2022
  57. SHEN W, Wang Q, Wang Z, Liu M, et al
    Specific Monoclonal Antibodies Targeting Unique HA Epitopes Block H7N9 Influenza A Viral Replication.
    J Virol. 2022 Aug 29:e0123822. doi: 10.1128/jvi.01238.
    >> Share

  58. FILES JK, Sterrett S, Henostroza S, Fucile C, et al
    HLA-II-Associated HIV-1 Adaptation Decreases CD4(+) T-Cell Responses in HIV-1 Vaccine Recipients.
    J Virol. 2022 Aug 24:e0119122. doi: 10.1128/jvi.01191.
    >> Share

  59. NEERUKONDA SN, Wang R, Vassell R, Baha H, et al
    Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants.
    J Virol. 2022 Aug 24:e0114022. doi: 10.1128/jvi.01140.
    >> Share

  60. GUPTA SL, Mantus G, Manning KE, Ellis M, et al
    Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults.
    J Virol. 2022 Aug 17:e0058222. doi: 10.1128/jvi.00582.
    >> Share

  61. KEEP S, Stevenson-Leggett P, Dowgier G, Foldes K, et al
    A Temperature-Sensitive Recombinant of Avian Coronavirus Infectious Bronchitis Virus Provides Complete Protection against Homologous Challenge.
    J Virol. 2022 Aug 16:e0110022. doi: 10.1128/jvi.01100.
    >> Share

  62. SHI J, Zheng J, Tai W, Verma AK, et al
    A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    J Virol. 2022 Aug 16:e0011822. doi: 10.1128/jvi.00118.
    >> Share

  63. VERMILLION MS, Dearing J, Zhang Y, Adney DR, et al
    Animal Models of Enterovirus D68 Infection and Disease.
    J Virol. 2022;96:e0083322.
    >> Share

  64. DODANTENNA N, Ranathunga L, Chathuranga WAG, Weerawardhana A, et al
    African Swine Fever Virus EP364R and C129R Target Cyclic GMP-AMP To Inhibit the cGAS-STING Signaling Pathway.
    J Virol. 2022;96:e0102222.
    >> Share

  65. CHAN M, Tiwary M, Wu HL, Tailor N, et al
    Pandemic 1918 Influenza Virus Does Not Cause Lethal Infection in Rhesus or Cynomolgus Macaques.
    J Virol. 2022 Aug 4:e0072822. doi: 10.1128/jvi.00728.
    >> Share

  66. ABBADI N, Nagashima K, Pena-Briseno A, Ross TM, et al
    Differential Recognition of Computationally Optimized H3 Hemagglutinin Influenza Vaccine Candidates by Human Antibodies.
    J Virol. 2022 Aug 2:e0089622. doi: 10.1128/jvi.00896.
    >> Share

  67. YUAN M, Chen X, Zhu Y, Dong X, et al
    A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern.
    J Virol. 2022 Aug 2:e0077522. doi: 10.1128/jvi.00775.
    >> Share

    July 2022
  68. DING M, Dang W, Liu H, Xu F, et al
    Combinational Deletions of MGF360-9L and MGF505-7R Attenuated Highly Virulent African Swine Fever Virus and Conferred Protection against Homologous Challenge.
    J Virol. 2022;96:e0032922.
    >> Share

  69. VUONO E, Ramirez-Medina E, Silva E, Rai A, et al
    Deletion of the H108R Gene Reduces Virulence of the Pandemic Eurasia Strain of African Swine Fever Virus with Surviving Animals Being Protected against Virulent Challenge.
    J Virol. 2022;96:e0054522.
    >> Share

  70. WANG M, Bohorquez JA, Munoz-Gonzalez S, Gerber M, et al
    Removal of the E(rns) RNase Activity and of the 3' Untranslated Region Polyuridine Insertion in a Low-Virulence Classical Swine Fever Virus Triggers a Cytokine Storm and Lethal Disease.
    J Virol. 2022;96:e0043822.
    >> Share

  71. PUSNIK J, Konig J, Mai K, Richter E, et al
    Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response.
    J Virol. 2022 Jul 12:e0076022. doi: 10.1128/jvi.00760.
    >> Share

  72. CHAPARIAN RR, Harding AT, Hamele CE, Riebe K, et al
    A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice.
    J Virol. 2022 Jul 12:e0068922. doi: 10.1128/jvi.00689.
    >> Share

  73. RAMIREZ-MEDINA E, Vuono E, Silva E, Rai A, et al
    Evaluation of the Deletion of MGF110-5L-6L on Swine Virulence from the Pandemic Strain of African Swine Fever Virus and Use as a DIVA Marker in Vaccine Candidate ASFV-G-DeltaI177L.
    J Virol. 2022 Jul 11:e0059722. doi: 10.1128/jvi.00597.
    >> Share

  74. VAN DE VEN K, van Dijken H, Du W, de Heij F, et al
    Varying Viral Replication and Disease Profiles of H2N2 Influenza in Ferrets Is Associated with Virus Isolate and Inoculation Route.
    J Virol. 2022 Jul 11:e0073222. doi: 10.1128/jvi.00732.
    >> Share

    June 2022
  75. VAN OOSTEN L, Yan K, Rawle DJ, Le TT, et al
    An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice.
    J Virol. 2022 Jun 29:e0084422. doi: 10.1128/jvi.00844.
    >> Share

  76. SHEWARD DJ, Hermanus T, Murrell B, Garrett N, et al
    HIV Coinfection Provides Insights for the Design of Vaccine Cocktails to Elicit Broadly Neutralizing Antibodies.
    J Virol. 2022 Jun 27:e0032422. doi: 10.1128/jvi.00324.
    >> Share

  77. KIM A, Lee G, Hwang JH, Park JH, et al
    BacMam Expressing Highly Glycosylated Porcine Interferon Alpha Induces Robust Antiviral and Adjuvant Effects against Foot-and-Mouth Disease Virus in Pigs.
    J Virol. 2022;96:e0052822.
    >> Share

  78. OLCZAK P, Matsui K, Wong M, Alvarez J, et al
    RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer.
    J Virol. 2022 Jun 15:e0056622. doi: 10.1128/jvi.00566.
    >> Share

  79. SUN C, Yuan RY, Xie C, Sun JF, et al
    Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines.
    J Virol. 2022 Jun 14:e0038322. doi: 10.1128/jvi.00383.
    >> Share

  80. LIN J, Law R, Korosec CS, Zhou C, et al
    Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
    J Virol. 2022 Jun 14:e0050922. doi: 10.1128/jvi.00509.
    >> Share

  81. CHEN X, Li J, Yang L, Zhou Y, et al
    Immunoglobin G Sero-Dynamics Aided Host Specific Linear Epitope Identification and Differentiation of Infected from Vaccinated Hosts.
    J Virol. 2022 Jun 6:e0014322. doi: 10.1128/jvi.00143.
    >> Share

    May 2022
  82. PRICE GE, Lo CY, Misplon JA, Epstein SL, et al
    Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require Antibodies.
    J Virol. 2022 May 31:e0032022. doi: 10.1128/jvi.00320.
    >> Share

  83. DELVA JL, Van Waesberghe C, Van Den Broeck W, Lamote JA, et al
    The Attenuated Pseudorabies Virus Vaccine Strain Bartha Hyperactivates Plasmacytoid Dendritic Cells by Generating Large Amounts of Cell-Free Virus in Infected Epithelial Cells.
    J Virol. 2022 May 23:e0219921. doi: 10.1128/jvi.02199.
    >> Share

  84. VANDOORN E, Stadejek W, Parys A, Chepkwony S, et al
    Pathobiology of an NS1-Truncated H3N2 Swine Influenza Virus Strain in Pigs.
    J Virol. 2022 May 12:e0051922. doi: 10.1128/jvi.00519.
    >> Share

  85. LINVILLE AC, Rico AB, Teague H, Binsted LE, et al
    Dysregulation of Cellular VRK1, BAF, and Innate Immune Signaling by the Vaccinia Virus B12 Pseudokinase.
    J Virol. 2022 May 11:e0039822. doi: 10.1128/jvi.00398.
    >> Share

  86. LUCAS CJ, Davenport BJ, Carpentier KS, Tinega AN, et al
    Two Conserved Phenylalanine Residues in the E1 Fusion Loop of Alphaviruses Are Essential for Viral Infectivity.
    J Virol. 2022;96:e0006422.
    >> Share

  87. TU JJ, Kumar A, Giorgi EE, Eudailey J, et al
    Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses.
    J Virol. 2022 May 10:e0023122. doi: 10.1128/jvi.00231.
    >> Share

    April 2022
  88. MANTLO EK, Maruyama J, Manning JT, Wanninger TG, et al
    Machupo Virus with Mutations in the Transmembrane Domain and Glycosylation Sites of the Glycoprotein Is Attenuated and Immunogenic in Animal Models of Bolivian Hemorrhagic Fever.
    J Virol. 2022;96:e0020922.
    >> Share

  89. KIRKPATRICK ROUBIDOUX E, Sano K, McMahon M, Carreno JM, et al
    Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies.
    J Virol. 2022 Apr 21:e0033222. doi: 10.1128/jvi.00332.
    >> Share

  90. NUNEZ CASTREJON AM, O'Rourke SM, Kauvar LM, DuBois RM, et al
    Structure-Based Design and Antigenic Validation of Respiratory Syncytial Virus G Immunogens.
    J Virol. 2022;96:e0220121.
    >> Share

  91. DESCHAMBAULT Y, Lynch J, Warner B, Tierney K, et al
    Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
    J Virol. 2022 Apr 12:e0038922. doi: 10.1128/jvi.00389.
    >> Share

  92. TEMPLETON CW, Traktman P
    UV Irradiation of Vaccinia Virus-Infected Cells Impairs Cellular Functions, Introduces Lesions into the Viral Genome, and Uncovers Repair Capabilities for the Viral Replication Machinery.
    J Virol. 2022 Apr 11:e0213721. doi: 10.1128/jvi.02137.
    >> Share

  93. KONG XW, Zhang X, Bu GL, Xu HQ, et al
    Vesicular Stomatitis Virus-Based Epstein-Barr Virus Vaccines Elicit Strong Protective Immune Responses.
    J Virol. 2022 Apr 11:e0033622. doi: 10.1128/jvi.00336.
    >> Share

  94. BRIGGS K, Kirby C, Beavis AC, Zengel J, et al
    Immunogenicity of Mumps Virus Genotype G Vaccine Candidates in Jeryl Lynn-Immunized Mice.
    J Virol. 2022 Apr 7:e0198321. doi: 10.1128/jvi.01983.
    >> Share

  95. FARIAS JP, da Silva PS, Fogaca MMC, Santana IVR, et al
    The COVID-19 Humoral Immunological Status Induced by CoronaVac and AstraZeneca Vaccines Significantly Benefits from a Booster Shot with the Pfizer Vaccine.
    J Virol. 2022 Apr 7:e0017722. doi: 10.1128/jvi.00177.
    >> Share

  96. KLASSE PJ, Moore JP
    Reappraising the Value of HIV-1 Vaccine Correlates of Protection Analyses.
    J Virol. 2022 Apr 6:e0003422. doi: 10.1128/jvi.00034.
    >> Share

    March 2022
  97. LIU MQ, Jiang RD, Guo J, Chen Y, et al
    Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice.
    J Virol. 2022 Mar 28:e0016922. doi: 10.1128/jvi.00169.
    >> Share

  98. NGUYEN HT, Qualizza A, Anang S, Zhao M, et al
    Functional and Highly Cross-Linkable HIV-1 Envelope Glycoproteins Enriched in a Pretriggered Conformation.
    J Virol. 2022 Mar 28:e0166821. doi: 10.1128/jvi.01668.
    >> Share

  99. EICHHOLZ K, Tran TH, Cheneau C, Tran TTP, et al
    Adenovirus-alpha-Defensin Complexes Induce NLRP3-Associated Maturation of Human Phagocytes via Toll-Like Receptor 4 Engagement.
    J Virol. 2022;96:e0185021.
    >> Share

  100. RATHAKRISHNAN A, Connell S, Petrovan V, Moffat K, et al
    Differential Effect of Deleting Members of African Swine Fever Virus Multigene Families 360 and 505 from the Genotype II Georgia 2007/1 Isolate on Virus Replication, Virulence, and Induction of Protection.
    J Virol. 2022;96:e0189921.
    >> Share

  101. CHEN SMY, Wong YC, Yim LY, Zhang H, et al
    Enhanced Cross-Reactive and Polyfunctional Effector-Memory T Cell Responses by ICVAX-a Human PD1-Based Bivalent HIV-1 Gag-p41 Mosaic DNA Vaccine.
    J Virol. 2022 Mar 17:e0216121. doi: 10.1128/jvi.02161.
    >> Share

  102. ALLEN JD, Ross TM
    Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019.
    J Virol. 2022 Mar 15:e0165221. doi: 10.1128/jvi.01652.
    >> Share

    February 2022
  103. ELSAYED H, Nabi G, McKinstry WJ, Khoo KK, et al
    Correction for Elsayed et al., "Intrastructural Help: Harnessing T Helper Cells Induced by Licensed Vaccines for Improvement of HIV Env Antibody Responses to Virus-Like Particle Vaccines".
    J Virol. 2022;96:e0195421.
    >> Share

  104. UTRILLA-TRIGO S, Jimenez-Cabello L, Calvo-Pinilla E, Marin-Lopez A, et al
    The Combined Expression of the Nonstructural Protein NS1 and the N-Terminal Half of NS2 (NS21-180) by ChAdOx1 and MVA Confers Protection against Clinical Disease in Sheep upon Bluetongue Virus Challenge.
    J Virol. 2022;96:e0161421.
    >> Share

  105. ZHANG YN, Zhang ZR, Li N, Pei XR, et al
    High titer self-propagating capsidless Chikungunya virus generated in Vero cells as a strategy for alphavirus vaccine development.
    J Virol. 2022 Feb 2:JVI0148021. doi: 10.1128/JVI.01480.
    >> Share

  106. ROSU ME, Kok A, Bestebroer TM, de Meulder D, et al
    Contribution of neuraminidase to the efficacy of seasonal split influenza vaccines in the ferret model.
    J Virol. 2022 Feb 2:jvi0195921. doi: 10.1128/jvi.01959.
    >> Share

    January 2022
  107. LI Y, Yuan M, Han Y, Xie L, et al
    The Unique Glycosylation at Position 986 on the E2 Glycoprotein of Classical Swine Fever Virus Is Responsible for Viral Attenuation and Protection against Lethal Challenge.
    J Virol. 2022;96:e0176821.
    >> Share

  108. GMYREK GB, Predki P, Gershburg E, Carr DJJ, et al
    Noncognate Signals Drive Enhanced Effector CD8(+) T Cell Responses through an IFNAR1-Dependent Pathway after Infection with the Prototypic Vaccine, 0DeltaNLS, against Herpes Simplex Virus 1.
    J Virol. 2022 Jan 19:JVI0172421. doi: 10.1128/JVI.01724.
    >> Share

  109. KEEP S, Stevenson-Leggett P, Dowgier G, Everest H, et al
    Identification of amino acids within non-structural proteins 10 and 14 of the avian coronavirus infectious bronchitis virus that result in attenuation in vivo and in ovo.
    J Virol. 2022 Jan 19:jvi0205921. doi: 10.1128/jvi.02059.
    >> Share

  110. PETROVAN V, Rathakrishnan A, Islam M, Goatley LC, et al
    Role of African Swine Fever Virus Proteins EP153R and EP402R in Reducing Viral Persistence in Blood and Virulence in Pigs Infected with BeninDeltaDP148R.
    J Virol. 2022;96:e0134021.
    >> Share

  111. KIMBLE JB, Wymore Brand M, Kaplan BS, Gauger P, et al
    Vaccine-associated enhanced respiratory disease following influenza virus infection in ferrets recapitulates the model in pigs.
    J Virol. 2022 Jan 5:JVI0172521. doi: 10.1128/JVI.01725.
    >> Share

  112. MCGREGOR J, Hardy JM, Lay CS, Boo I, et al
    Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs.
    J Virol. 2022 Jan 5:JVI0167521. doi: 10.1128/JVI.01675.
    >> Share

    December 2021
  113. HUANG Y, Skarlupka AL, Jang H, Blas-Machado U, et al
    SARS-CoV-2 and Influenza A virus Co-infections in Ferrets.
    J Virol. 2021 Dec 22:JVI0179121. doi: 10.1128/JVI.01791.
    >> Share

  114. CAO K, Wang X, Peng H, Ding L, et al
    A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice.
    J Virol. 2021 Dec 15:JVI0157821. doi: 10.1128/JVI.01578.
    >> Share

  115. MUCKER EM, Golden JW, Hammerbeck CD, Kishimori JM, et al
    A nucleic acid-based orthopoxvirus vaccine targeting the vaccinia virus L1, A27, B5 and A33 proteins protects rabbits against lethal rabbitpox virus aerosol challenge.
    J Virol. 2021 Dec 1:JVI0150421. doi: 10.1128/JVI.01504.
    >> Share

    November 2021
  116. WU C, He Y, Zhao J, Luo K, et al
    Exacerbated AIDS progression by PD-1 blockade during therapeutic vaccination in chronically SIV-infected rhesus macaques after ART treatment interruption.
    J Virol. 2021 Nov 24:JVI0178521. doi: 10.1128/JVI.01785.
    >> Share

  117. APPELBERG S, John L, Pardi N, Vegvari A, et al
    Nucleoside-modified mRNA vaccines protect IFNAR(-/-) mice against Crimean Congo hemorrhagic fever virus infection.
    J Virol. 2021 Nov 24:JVI0156821. doi: 10.1128/JVI.01568.
    >> Share

  118. BURCKHARDT RM, Dennehy JJ, Poon LLM, Saif LJ, et al
    Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters.
    J Virol. 2021 Nov 24:JVI0197321. doi: 10.1128/JVI.01973.
    >> Share

  119. ZHANG H, Zheng H, Guo P, Hu L, et al
    Correction for Zhang et al., "Broadly Protective CD8(+) T Cell Immunity to Highly Conserved Epitopes Elicited by Heat Shock Protein gp96-Adjuvanted Influenza Monovalent Split Vaccine".
    J Virol. 2021;95:e0175021.
    >> Share

  120. SOUZA CK, Anderson TK, Chang J, Venkatesh D, et al
    Antigenic distance between North American swine and human seasonal H3N2 influenza A viruses as an indication of zoonotic risk to humans.
    J Virol. 2021 Nov 10:JVI0137421. doi: 10.1128/JVI.01374.
    >> Share

  121. VANBLARGAN LA, Milutinovic PS, Goo L, DeMaso CR, et al
    Dengue Virus Serotype 1 Conformational Dynamics Confers Virus Strain-Dependent Patterns of Neutralization by Polyclonal Sera.
    J Virol. 2021;95:e0095621.
    >> Share

  122. ZHANG Y, Ke J, Zhang J, Yang J, et al
    African Swine Fever Virus Bearing an I226R Gene Deletion Elicits Robust Immunity in Pigs to African Swine Fever.
    J Virol. 2021;95:e0119921.
    >> Share

  123. MIELKE D, Stanfield-Oakley S, Borate B, Fisher LH, et al
    Selection of HIV Envelope strains for standardized assessments of vaccine-elicited antibody-dependent cellular cytotoxicity (ADCC)-mediating antibodies.
    J Virol. 2021 Nov 3:JVI0164321. doi: 10.1128/JVI.01643.
    >> Share

  124. CARTEN JD, Greseth M, Traktman P
    Structure-function analysis of two interacting vaccinia proteins that are critical for viral morphogenesis: L2 and A30.5.
    J Virol. 2021 Nov 3:JVI0157721. doi: 10.1128/JVI.01577.
    >> Share

    October 2021
  125. YU J, Collins ND, Mercado NB, McMahan K, et al
    Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery Against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques.
    J Virol. 2021 Oct 27:JVI0159921. doi: 10.1128/JVI.01599.
    >> Share

  126. SCHORCHT A, Cottrell CA, Pugach P, Ringe RP, et al
    The glycan hole area of HIV-1 envelope trimers contributes prominently to the induction of autologous neutralization.
    J Virol. 2021 Oct 20:JVI0155221. doi: 10.1128/JVI.01552.
    >> Share

  127. BELTRAN-PAVEZ C, Bontjer I, Gonzalez N, Pernas M, et al
    Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle (VLP) Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses.
    J Virol. 2021 Oct 20:JVI0134321. doi: 10.1128/JVI.01343.
    >> Share

  128. GLADUE DP, Ramirez-Medina E, Vuono E, Silva E, et al
    Deletion of the A137R Gene from the Pandemic Strain of African Swine Fever Virus Attenuates the Strain and Offers Protection against the Virulent Pandemic Virus.
    J Virol. 2021;95:e0113921.
    >> Share

  129. GAO J, Klenow L, Parsons L, Malik T, et al
    Design of the Recombinant Influenza Neuraminidase Antigen is Crucial for its Biochemical Properties and Protective Efficacy.
    J Virol. 2021 Oct 6:JVI0116021. doi: 10.1128/JVI.01160.
    >> Share

  130. CHEN C, Zhang C, Li H, Wang Z, et al
    TLR4 regulates rabies virus-induced humoral immunity through recruitment of cDC2 to lymph organs.
    J Virol. 2021 Oct 6:JVI0082921. doi: 10.1128/JVI.00829.
    >> Share

    September 2021
  131. SIEGERS JY, Dhanasekaran V, Xie R, Deng YM, et al
    Genetic and Antigenic Characterization of an Influenza A(H3N2) Outbreak in Cambodia and the Greater Mekong Subregion during the COVID-19 Pandemic, 2020.
    J Virol. 2021 Sep 29:JVI0126721. doi: 10.1128/JVI.01267.
    >> Share

  132. CHOI A, Koch M, Wu K, Dixon G, et al
    Serum Neutralizing Activity of mRNA-1273 Against SARS-CoV-2 Variants.
    J Virol. 2021 Sep 22:JVI0131321. doi: 10.1128/JVI.01313.
    >> Share

  133. KIRCHENBAUM GA, Sautto GA, Richardson RA, Ecker JW, et al
    A competitive hemagglutination inhibition assay for dissecting functional antibody activity to influenza virus.
    J Virol. 2021 Sep 15:JVI0237920. doi: 10.1128/JVI.02379.
    >> Share

    July 2021
  134. DONG H, Lu Y, Zhang Y, Mu S, et al
    A Heat-Induced Mutation on VP1 of Foot-and-Mouth Disease Virus Serotype O Enhanced Capsid Stability and Immunogenicity.
    J Virol. 2021;95:e0017721.
    >> Share

    June 2021
  135. VAN HAAREN MM, McCoy LE, Torres JL, Lee W, et al
    Antibodies from rabbits immunized with HIV-1 clade B SOSIP trimers can neutralize multiple clade B viruses by destabilizing the envelope glycoprotein.
    J Virol. 2021 Jun 2:JVI0009421. doi: 10.1128/JVI.00094.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016